- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
CABG Versus PCI in the Treatment of Diabetic Patients Affected by Coronary Artery Disease
-
- Nicolini Francesco
- Cardiac Surgery Unit, Department of Clinical and Experimental Medicine, University of Parma
-
- Agostinelli Andrea
- Cardiac Surgery Unit, Cardio-Nephro-Pulmonary Department, Parma Hospital
-
- Vezzani Antonella
- Cardiac Surgery Unit, Cardio-Nephro-Pulmonary Department, Parma Hospital
-
- Benassi Filippo
- Cardiac Surgery Unit, Cardio-Nephro-Pulmonary Department, Parma Hospital
-
- Gherli Tiziano
- Cardiac Surgery Unit, Department of Clinical and Experimental Medicine, University of Parma
Bibliographic Information
- Other Title
-
- Which is the Best Option?
Search this article
Description
Surgical coronary revascularization and percutaneous coronary intervention were demonstrated to be effective treatments for coronary artery disease. However, the optimal revascularization strategy remains unclear in certain patient subsets. The recently published Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial is a randomized study evaluating the use of CABG versus PCI in diabetic patients with multivessel coronary disease. The purpose of this study was to review the available literature based on randomized trials and observational studies in order to allow clinicians to make evidence-based decisions when treating diabetic patients with multivessel coronary disease. The current evidence suggests that CABG should remain the standard of care for this patient population.
Journal
-
- International Heart Journal
-
International Heart Journal 55 (6), 469-473, 2014
International Heart Journal Association